Urogen Pharma Drug Patent Portfolio

Urogen Pharma's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Urogen Pharma News

Analysts anticipate strong sales performance for Urogen's potential treatment for bladder cancer

16 Oct, 2024

Financial firms are predicting strong sales for Urogen's new potential treatment for bladder cancer.

16 Oct, 2024

See More